Prospective Open Clinical and Genetic Study of Patients With Retinitis Pigmentosa

Inclusion Criteria: * Patient fulfill the clinical characteristics for Retinitis Pigmentosa (AD, AR, X-linked, sporadic) as defined by the Retinitis pigmentosa consortium * Results of perimetry for each eye show narrowing for 15 degrees or more. * Patient is familiar with Participant information sheet * Patient signed informed consent form Non-inclusion Criteria: * Participation in other clinical trials (or administration of investigational drugs) during 3 months prior inclusion * Any conditions limiting compliance (dementia, neuropsychiatric disease, drug and alcohol abuse etc.) * Medical history of traumatic injury of eyes, barotrauma, concussion, craniocerebral trauma, cerebrovascular accident * Congenital multiple development orbit and eye malformations Exclusion Criteria: * Patient's refusal from the further participation in the trial * Decompensated diabetes mellitus * Severe coronary artery disease * Chronic infectious disease * Patients with malignant tumors including postoperative period, patients receiving chemotherapy and/or radiotherapy